<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>PR.com Press Releases: Epitope Diagnostics, Inc. News</title>
		<link>https://www.PR.com/</link>
		<description>Latest news releases from PR.com for Epitope Diagnostics, Inc.</description>
		<lastBuildDate>Mon, 17 Aug 2026 01:26:36 -0400</lastBuildDate>
		<copyright>&#169; 2026 PR.com</copyright>
		<ttl>60</ttl>
		<language>en-us</language>
		<image>
			<url>https://www.PR.com/images/logo_white.jpg</url>
			<title>PR.com Press Releases: Epitope Diagnostics, Inc. News</title>
			<link>https://www.PR.com/</link>
			<width>68</width>
			<height>69</height>
			<description>PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles.</description>
		</image>
		<atom:link href="https://www.pr.com/rss/press-releases-2/267031.xml" rel="self" type="application/rss+xml" />
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/823168</guid>
			<title>Introducing EDI’s COVID-19 Nucleocapsid IgG Quantitative ELISA Kit</title>
			<pubDate>Wed, 14 Oct 2020 03:00:00 -0400</pubDate>
			<description>The EDI™ COVID-19 Nucleocapsid IgG Quantitative ELISA Kit is designed, developed &amp; produced for the quantitative measurement of human anti-COVID-19 (anti-SARS-CoV-2) IgG antibody in serum. The test uses a series of calibrators &amp; controls in order to determine a standard curve, which allows for specific, concentration-based results of patient samples, giving researchers &amp; healthcare providers access to quantitative [PR.com]</description>
			<link>https://www.pr.com/press-release/823168</link>
			<dc:creator>Epitope Diagnostics, Inc.</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/807328</guid>
			<title>Epitope Diagnostics Has Proudly Introduced Immunoassay Kits Exclusively for the Qualitative Detection of COVID-19</title>
			<pubDate>Fri, 06 Mar 2020 03:00:00 -0500</pubDate>
			<description>The EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit and EDI™ Novel Coronavirus COVID-19 IgM ELISA Kits. With proven results from clinical testing in China, Epitope Diagnostics, Inc. is eager to cooperate and collaborate to combat the current COVID-19 situation. [PR.com]</description>
			<link>https://www.pr.com/press-release/807328</link>
			<dc:creator>Epitope Diagnostics, Inc.</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/767946</guid>
			<title>Epitope Diagnostics, Inc. Certifies Its Total 25-OH Vitamin D EIA Kit Through the CDC’s Vitamin D Standardization-Certification Program (VDSCP)</title>
			<pubDate>Sun, 21 Oct 2018 03:00:00 -0400</pubDate>
			<description>Epitope Diagnostics, Inc. (EDI), is pleased to announce it has received certification for the Vitamin D Standardization Program (VDSP) for vitamin D measurement in the EDI&#8482; Total 25-OH Vitamin D EIA Kit. CDC&#8217;s Vitamin D Standardization-Certification Program (VDSCP) evaluates the accuracy and reliability of vitamin D tests using well-established procedures, and certifies those that have a certain accuracy and [PR.com]</description>
			<link>https://www.pr.com/press-release/767946</link>
			<dc:creator>Epitope Diagnostics, Inc.</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/765409</guid>
			<title>Epitope Diagnostics, Inc. Joins MetroConnect to Expand International Growth</title>
			<pubDate>Sun, 23 Sep 2018 03:00:00 -0400</pubDate>
			<description>Epitope Diagnostics, Inc. is pleased to announce it has been selected to take part in MetroConnect 2018, an export assistance program run by the World Trade Center San Diego (WTC) and designed to help San Diego companies accelerate their global growth.  This program will allow Epitope Diagnostics to have further spending on R&#38;D in order to stay competitive in the IVD market by manufacturing niche products that call [PR.com]</description>
			<link>https://www.pr.com/press-release/765409</link>
			<dc:creator>Epitope Diagnostics, Inc.</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/657834</guid>
			<title>Studies Use Epitope Diagnostics’ ELISA Kit to Establish Chromogranin A as a Potential Prognostic Marker in Prostate Cancer Patients Treated with Antiandrogens</title>
			<pubDate>Thu, 11 Feb 2016 12:43:00 -0500</pubDate>
			<description>Italian research group uses Epitope Diagnostics&#039; Chromogranin A ELISA kit in study to determine CgA as a potential prognostic marker in castration-resistant prostate cancer patients treated in abiraterone or enzalutamide. [PR.com]</description>
			<link>https://www.pr.com/press-release/657834</link>
			<dc:creator>Epitope Diagnostics, Inc.</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/635454</guid>
			<title>Epitope Diagnostics Introduces Novel Fecal NGAL Specific ELISA Kit for Inflammatory Bowel Disease</title>
			<pubDate>Tue, 01 Sep 2015 16:43:09 -0400</pubDate>
			<description>Epitope Diagnostics introduces its novel fecal neutrophil gelatinase-associated lipocalin (NGAL) ELISA kit. This is the first commercial kit that is developed for measurement of NGAL levels in human stool sample. Fecal NGAL is potentially a better marker than those currently used in clinical practice. [PR.com]</description>
			<link>https://www.pr.com/press-release/635454</link>
			<dc:creator>Epitope Diagnostics, Inc.</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/618993</guid>
			<title>Epitope Diagnostics Launches a Novel 25-OH Vitamin D ELISA Kit</title>
			<pubDate>Mon, 11 May 2015 08:00:00 -0400</pubDate>
			<description>Epitope Diagnostics, Inc. has added a new ELISA kit to their product line to detect the total amount of 25-OH vitamin D2 and D3 in serum or plasma sample. This is a monoclonal antibody-based ELISA with a unique vitamin D releasing buffer for easy and reliable measurement of 25-OH vitamin D. [PR.com]</description>
			<link>https://www.pr.com/press-release/618993</link>
			<dc:creator>Epitope Diagnostics, Inc.</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/618994</guid>
			<title>Epitope Diagnostics Expands Infectious Disease Product Line with Clostridium Difficile Family of Tests</title>
			<pubDate>Sun, 10 May 2015 03:00:00 -0400</pubDate>
			<description>Epitope Diagnostics, Inc. developed and produced a new ELISA Kit and rapid test with accessories for the detection of Clostridium difficile specific glutamate dehydrogenase (GDH). [PR.com]</description>
			<link>https://www.pr.com/press-release/618994</link>
			<dc:creator>Epitope Diagnostics, Inc.</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/576654</guid>
			<title>Epitope Diagnostics, Inc. Introduces New 2-Hour Human ACTH ELISA Kit</title>
			<pubDate>Tue, 19 Aug 2014 03:00:00 -0400</pubDate>
			<description>Epitope Diagnostics releases a new, highly sensitive and robust human ACTH ELISA kit which can be completed in 2 hours, increasing the efficiency of clinical laboratory operations. [PR.com]</description>
			<link>https://www.pr.com/press-release/576654</link>
			<dc:creator>Epitope Diagnostics, Inc.</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/554275</guid>
			<title>Epitope Diagnostics, Inc. Expands Product Panel with New Set of H. Pylori Antigen ELISA Kits and Novel Sample Collection Device</title>
			<pubDate>Tue, 22 Apr 2014 10:00:00 -0400</pubDate>
			<description>Epitope Diagnostics, Inc. has launched two user-friendly fecal Helicobacter pylori (H. pylori) antigen ELISA kits, along with a new sample collection device. One ELISA assay is qualitative while the other is quantitative, allowing for both the detection and measurement of active H. pylori antigen. H. pylori is a bacterium which causes infectious stomach disease and is linked to stomach cancer. A positive H. pylori antigen [PR.com]</description>
			<link>https://www.pr.com/press-release/554275</link>
			<dc:creator>Epitope Diagnostics, Inc.</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/521528</guid>
			<title>Epitope Diagnostics Launches the Second Generation Immunoassay Kits Exclusively for the Quantitative Measurement of Antibody Drug Conjugate  (ADC) Levels</title>
			<pubDate>Sat, 12 Oct 2013 03:00:00 -0400</pubDate>
			<description>Epitope Diagnostics has recently launched second-generation ADC kits exclusively for the quantitative measurement of DM1-, MMAE-, and MMAF-ADC level. These kits measure both humanized monoclonal antibody based ADC and mouse monoclonal antibody based ADC. Additional benefits for testing PK samples from mice are utilized by these second generation kits. [PR.com]</description>
			<link>https://www.pr.com/press-release/521528</link>
			<dc:creator>Epitope Diagnostics, Inc.</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/498659</guid>
			<title>Epitope Diagnostics Launches the First Commercially Available Immunoassay Kits Exclusively for the Quantitative Measurement of Antibody Drug Conjugate Level (ADC)</title>
			<pubDate>Thu, 20 Jun 2013 03:00:00 -0400</pubDate>
			<description>Epitope Diagnostics has proudly introduced immunoassay kits exclusively for the quantitative measurement of antibody drug conjugate level (ADC). These kits include the EDI™ Mertansine (DM1) ADC EIA Kit, EDI™ Monomethylauristatin F (MMAF) ADC EIA Kit, and the EDI™ Monomethylauristatin E (MMAE) ADC EIA Kit. This technology, together with groundbreaking applications such as Genentech&#039;s Kadcyla (Ado-Trastuzumab [PR.com]</description>
			<link>https://www.pr.com/press-release/498659</link>
			<dc:creator>Epitope Diagnostics, Inc.</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/494591</guid>
			<title>The EDI Human Intact FGF-21 ELISA Kit is the First Immunoassay Kit That Exclusively Measures Human Intact FGF-21</title>
			<pubDate>Fri, 31 May 2013 03:00:00 -0400</pubDate>
			<description>Epitope Diagnostics is pleased to introduce a brand new ELISA kit for the quantitative determination of β-Klotho &amp; FGF Receptor Active Human Intact FGF-21 level in EDTA-plasma or serum. This assay measures human intact FGF-21, instead of FGF-21 fragments like similar commercially available kits on the market today. [PR.com]</description>
			<link>https://www.pr.com/press-release/494591</link>
			<dc:creator>Epitope Diagnostics, Inc.</dc:creator>
		</item>
	</channel>
</rss>